Catalyst Wire Dossier Catalyst Wire Dossier

PEG-IFN-α-2b

pegylated interferon alfa-2b
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PEG-IFN-α-2b, covering 2019-06-20 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B [Phase 4]

See pricing